Home ETF List About

Portfolio Holdings Detail for ISIN IE00B441G979
Stock Name / FundiShares MSCI World EUR Hedged UCITS ETF (Acc)
IssuerBlackrock
Entity holding fund iShares V Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300QETNU1W5JY7Z94
ETF TickerIBCH(EUR) F
ETF TickerIBCH.DE(EUR) CXE
ETF TickerIWDE.AS(EUR) CXE
ETF TickerIWDE.LS(EUR) CXE
ETF TickerIWDE.MI(EUR) CXE
ETF TickerIWDEz(EUR) CXE
ETF TickerIWDE(EUR) Euronext Amsterdam

Holdings detail for EW

Stock NameEdwards Lifesciences Corp
TickerEW(USD) NYSE
TYPECommon Stock
CountryUSA
ISINUS28176E1082
LEIYA13X31F3V31L8TMPR58

Show aggregate EW holdings

News associated with EW

Edwards Lifesciences (NYSE:EW) Cut to Buy at Wall Street Zen
Edwards Lifesciences (NYSE:EW – Get Free Report) was downgraded by analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a note issued to investors on Saturday. A number of other research analysts have also issued reports on the company. Wells Fargo & Company boosted their price objective on Edwards Lifesciences […] - 2025-09-15 05:40:50
Here Are Billionaire Ken Griffin's 5 Biggest Stock Holdings
Key PointsKen Griffin founded the hedge fund firm Citadel. - 2025-09-09 12:44:48
Top Stock Reports for Apple, Novartis & Charles Schwab
Apple grows Services to 1B+ paid subscribers, while Novartis lifts guidance and Schwab rides higher rates to asset gains. - 2025-09-04 17:29:00
Atria Wealth Solutions Inc. Sells 29,763 Shares of Edwards Lifesciences Corporation (NYSE:EW)
Atria Wealth Solutions Inc. cut its position in shares of Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 81.7% during the 1st quarter, HoldingsChannel reports. The firm owned 6,662 shares of the medical research company’s stock after selling 29,763 shares during the period. Atria Wealth Solutions Inc.’s holdings in Edwards Lifesciences were worth $483,000 as […] - 2025-08-14 05:04:55
Edwards Lifesciences (NYSE:EW) Raised to Buy at BTIG Research
Edwards Lifesciences (NYSE:EW – Get Free Report) was upgraded by investment analysts at BTIG Research from a “neutral” rating to a “buy” rating in a note issued to investors on Tuesday, Marketbeat reports. The firm currently has a $100.00 target price on the medical research company’s stock. BTIG Research’s price target points to a potential […] - 2025-07-31 03:02:52
Edwards Lifesciences (NYSE:EW) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Edwards Lifesciences (NYSE:EW – Free Report) from a hold rating to a buy rating in a research note issued to investors on Saturday. Several other research analysts have also weighed in on EW. Wells Fargo & Company lifted their price objective on Edwards Lifesciences from $80.00 to $84.00 and […] - 2025-07-29 02:58:49
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism
The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 13:25:48
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism
The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 12:26:28
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism
The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 09:49:10
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism
The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 08:57:30
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism
The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 07:43:41
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism
The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 04:16:07
Edwards Lifesciences (NYSE:EW) Price Target Raised to $82.00
Edwards Lifesciences (NYSE:EW – Free Report) had its price objective upped by Truist Financial from $81.00 to $82.00 in a research note published on Friday,Benzinga reports. They currently have a hold rating on the medical research company’s stock. A number of other research firms have also weighed in on EW. Wall Street Zen lowered shares […] - 2025-07-28 04:08:50
Edwards Lifesciences (NYSE:EW) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says
Edwards Lifesciences (NYSE:EW – Free Report) had its price target increased by JPMorgan Chase & Co. from $80.00 to $85.00 in a report published on Friday morning,Benzinga reports. JPMorgan Chase & Co. currently has a neutral rating on the medical research company’s stock. Several other brokerages also recently issued reports on EW. Wells Fargo & […] - 2025-07-28 04:08:48
Edwards Lifesciences (NYSE:EW) Price Target Raised to $95.00
Edwards Lifesciences (NYSE:EW – Free Report) had its price target raised by Barclays from $90.00 to $95.00 in a report published on Friday,Benzinga reports. Barclays currently has an overweight rating on the medical research company’s stock. A number of other equities analysts have also weighed in on the stock. Deutsche Bank Aktiengesellschaft lifted their price […] - 2025-07-28 02:46:53
Stifel Nicolaus Issues Positive Forecast for Edwards Lifesciences (NYSE:EW) Stock Price
Edwards Lifesciences (NYSE:EW – Free Report) had its target price upped by Stifel Nicolaus from $90.00 to $95.00 in a research report sent to investors on Friday morning,Benzinga reports. The brokerage currently has a buy rating on the medical research company’s stock. EW has been the topic of several other research reports. Evercore ISI increased […] - 2025-07-28 02:46:53
Edwards Lifesciences (NYSE:EW) Stock Price Expected to Rise, Robert W. Baird Analyst Says
Edwards Lifesciences (NYSE:EW – Free Report) had its target price boosted by Robert W. Baird from $78.00 to $79.00 in a research report report published on Friday morning,Benzinga reports. Robert W. Baird currently has a neutral rating on the medical research company’s stock. Other research analysts have also issued reports about the stock. Evercore ISI […] - 2025-07-28 02:46:51
Edwards Lifesciences (NYSE:EW) Price Target Raised to $80.00
Edwards Lifesciences (NYSE:EW – Free Report) had its target price lifted by Evercore ISI from $77.00 to $80.00 in a research report report published on Friday,Benzinga reports. The firm currently has an in-line rating on the medical research company’s stock. A number of other brokerages have also issued reports on EW. Argus upgraded shares of […] - 2025-07-28 02:46:51
Edwards Lifesciences (NYSE:EW) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says
Edwards Lifesciences (NYSE:EW – Free Report) had its price objective lifted by Wells Fargo & Company from $80.00 to $84.00 in a report released on Friday morning,Benzinga reports. They currently have an overweight rating on the medical research company’s stock. A number of other research analysts also recently commented on EW. Dbs Bank raised shares […] - 2025-07-28 02:46:49
Deutsche Bank Aktiengesellschaft Issues Positive Forecast for Edwards Lifesciences (NYSE:EW) Stock Price
Edwards Lifesciences (NYSE:EW – Free Report) had its price objective increased by Deutsche Bank Aktiengesellschaft from $85.00 to $94.00 in a research note issued to investors on Friday,Benzinga reports. The brokerage currently has a buy rating on the medical research company’s stock. Several other equities analysts have also issued reports on EW. Dbs Bank upgraded […] - 2025-07-28 02:46:49
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism
The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 02:37:03
Solid Corporate Earnings Results Support Stocks
The S&P 500 Index ($SPX ) (SPY ) today is up +0.25%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.19%. September E-mini S&P futures (ESU25 ) are up +0.18%, and September E-mini Nasdaq futures... - 2025-07-25 19:42:53
Solid Corporate Earnings Results Support Stocks
The S&P 500 Index ($SPX ) (SPY ) today is up +0.25%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.19%. September E-mini S&P futures (ESU25 ) are up +0.18%, and September E-mini Nasdaq futures... - 2025-07-25 14:56:19
Positive Earnings Results Lift Stocks
The S&P 500 Index ($SPX ) (SPY ) today is up +0.14%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.11%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.13%. September E-mini S&P futures (ESU25 ) are up +0.10%, and September E-mini Nasdaq futures... - 2025-07-25 14:23:43
Solid Corporate Earnings Results Support Stocks
The S&P 500 Index ($SPX ) (SPY ) today is up +0.25%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.19%. September E-mini S&P futures (ESU25 ) are up +0.18%, and September E-mini Nasdaq futures... - 2025-07-25 14:18:44
Positive Earnings Results Lift Stocks
The S&P 500 Index ($SPX ) (SPY ) today is up +0.14%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.11%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.13%. September E-mini S&P futures (ESU25 ) are up +0.10%, and September E-mini Nasdaq futures... - 2025-07-25 12:39:11
J.W. Cole Advisors Inc. Has $814,000 Stock Holdings in Edwards Lifesciences Corporation (NYSE:EW)
J.W. Cole Advisors Inc. raised its holdings in Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 220.2% in the 1st quarter, HoldingsChannel reports. The fund owned 11,224 shares of the medical research company’s stock after acquiring an additional 7,719 shares during the period. J.W. Cole Advisors Inc.’s holdings in Edwards Lifesciences were worth $814,000 at […] - 2025-07-25 05:12:50
Sigma Planning Corp Has $294,000 Position in Edwards Lifesciences Corporation (NYSE:EW)
Sigma Planning Corp boosted its holdings in Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 4.9% in the 1st quarter, HoldingsChannel.com reports. The firm owned 4,055 shares of the medical research company’s stock after acquiring an additional 191 shares during the quarter. Sigma Planning Corp’s holdings in Edwards Lifesciences were worth $294,000 as of its […] - 2025-07-21 05:06:55
Edwards Lifesciences Corporation (NYSE:EW) Position Lowered by Ballentine Partners LLC
Ballentine Partners LLC decreased its stake in shares of Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 6.8% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 5,109 shares of the medical research company’s stock after selling 375 shares during the period. Ballentine Partners LLC’s holdings […] - 2025-07-16 06:51:32
Alps Advisors Inc. Purchases Shares of 5,090 Edwards Lifesciences Corporation (NYSE:EW)
Alps Advisors Inc. bought a new position in Edwards Lifesciences Corporation (NYSE:EW – Free Report) during the 1st quarter, HoldingsChannel reports. The fund bought 5,090 shares of the medical research company’s stock, valued at approximately $369,000. A number of other hedge funds have also recently added to or reduced their stakes in the stock. Norges […] - 2025-07-16 06:01:07

iShares MSCI World EUR Hedged UCITS ETF (Acc) EW holdings

DateNumber of EW Shares HeldBase Market Value of EW SharesLocal Market Value of EW SharesChange in EW Shares HeldChange in EW Base ValueCurrent Price per EW Share HeldPrevious Price per EW Share Held
2025-09-26 (Friday)38,236USD 2,493,581USD 2,493,581
2025-09-25 (Thursday)38,236USD 2,464,800EW holding increased by 33924USD 2,464,8000USD 33,924 USD 64.4628 USD 63.5756
2025-09-24 (Wednesday)38,236USD 2,430,876USD 2,430,876
2025-09-18 (Thursday)38,236USD 2,420,596EW holding decreased by -5857USD 2,420,5960USD -5,857 USD 63.3067 USD 63.4599
2025-09-17 (Wednesday)38,236EW holding increased by 244USD 2,426,453EW holding increased by 19417USD 2,426,453244USD 19,417 USD 63.4599 USD 63.3564
2025-09-16 (Tuesday)37,992USD 2,407,036EW holding decreased by -50263USD 2,407,0360USD -50,263 USD 63.3564 USD 64.6794
2025-09-15 (Monday)37,992USD 2,457,299EW holding decreased by -55739USD 2,457,2990USD -55,739 USD 64.6794 USD 66.1465
2025-09-12 (Friday)37,992USD 2,513,038EW holding decreased by -14039USD 2,513,0380USD -14,039 USD 66.1465 USD 66.516
2025-09-11 (Thursday)37,992USD 2,527,077EW holding decreased by -8855USD 2,527,0770USD -8,855 USD 66.516 USD 66.7491
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of EW by Blackrock for IE00B441G979

Show aggregate share trades of EW

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-09-17BUY244 63.460* 65.71
2025-08-19BUY242 67.621* 65.63
2025-08-05SELL-120 68.511* 65.55 Profit of 7,866 on sale
2025-07-11SELL-132 66.747* 65.50 Profit of 8,646 on sale
2025-07-03BUY132 65.339* 65.48
2025-07-02BUY528 65.451* 65.48
2025-06-30BUY4,940 66.627* 65.46
2025-06-20SELL-600 64.116* 65.45 Profit of 39,270 on sale
2025-05-23BUY240 66.103* 65.05
2025-05-20BUY240 69.069* 64.91
2025-05-14BUY240 68.444* 64.57
2025-05-06BUY480 66.052* 64.31
2025-05-02BUY120 66.541* 64.21
2025-05-01BUY360 66.640* 64.15
2025-04-29BUY480 67.009* 64.01
2025-04-28BUY120 66.385* 63.95
2025-04-25BUY120 66.887* 63.87
2025-04-23BUY240 62.079* 63.85
2025-04-16BUY240 62.552* 64.16
2025-04-15BUY240 62.465* 64.22
2025-04-11BUY360 61.207* 64.45
2025-04-09BUY476 63.324* 64.64
2025-04-08BUY119 61.470* 64.77
2025-03-21BUY480 65.186* 64.08
2025-03-19BUY120 65.183* 63.83
2025-03-13BUY119 62.581* 63.83
2024-11-12BUY119 62.029* 0.00
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of EW

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19406,40201,881,72721.6%
2025-09-18684,5201,1773,487,98119.6%
2025-09-17484,3222101,603,06530.2%
2025-09-16811,9538562,055,93739.5%
2025-09-15611,0121041,391,88243.9%
2025-09-12982,9281,1002,234,22744.0%
2025-09-11514,2348281,919,00926.8%
2025-09-10669,7051491,567,94142.7%
2025-09-09441,4930925,37547.7%
2025-09-08632,5876721,251,93950.5%
2025-09-05334,037300934,00635.8%
2025-09-04380,3180871,93143.6%
2025-09-03701,9434591,170,96659.9%
2025-09-02397,396531,208,87232.9%
2025-08-29397,628800844,31847.1%
2025-08-28604,08741,056,65357.2%
2025-08-27493,608822875,88656.4%
2025-08-26480,2680868,21355.3%
2025-08-25796,55601,181,25867.4%
2025-08-22552,73911,011,67854.6%
2025-08-21873,0447981,597,74254.6%
2025-08-20847,84738,6991,560,10554.3%
2025-08-19613,349331,256,57748.8%
2025-08-18668,7194391,642,75940.7%
2025-08-15369,455513826,72344.7%
2025-08-14514,2026,112864,59359.5%
2025-08-13567,8572991,347,26442.1%
2025-08-12547,77312,3161,428,27738.4%
2025-08-11487,82301,152,63042.3%
2025-08-08661,697201,224,45854.0%
2025-08-07669,9319821,297,46951.6%
2025-08-06880,0284131,551,65956.7%
2025-08-05661,93381,592,64941.6%
2025-08-04572,1652681,310,04443.7%
2025-08-01678,0285,6001,308,86351.8%
2025-07-31831,4012491,817,97545.7%
2025-07-301,305,0166932,481,80852.6%
2025-07-291,129,154582,399,22347.1%
2025-07-28684,1012,1112,276,89230.0%
2025-07-251,669,7529206,616,25925.2%
2025-07-24455,59302,607,89817.5%
2025-07-23444,64501,978,11022.5%
2025-07-22447,8835112,702,92516.6%
2025-07-21568,293271,249,72745.5%
2025-07-18590,448592,118,40227.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.